TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)

NCT02920476 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Lung Carcinoma

Interventions

DRUG: TAS-102

Sponsor

University of Florida

Collaborators

[object Object]